First, we assessed the expression of ST2L on the membrane of peripheral blood CD123+ pDCs by flow cytometry and confirmed that healthy and SLE pDCs are already receptive of IL-33 signaling (Supplemental Figure 5, A and B). The gene discussed is IL33; the disease is systemic lupus erythematosus.